CI 1020 structure
|
Common Name | CI 1020 | ||
---|---|---|---|---|
CAS Number | 162256-50-0 | Molecular Weight | 506.50 | |
Density | 1.351g/cm3 | Boiling Point | 722.338ºC at 760 mmHg | |
Molecular Formula | C28H26O9 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 242.505ºC |
Use of CI 1020CI-1020 (PD156707) is an orally active and selective antagonist targeting endothelin (ETA) with an IC50 value of 0.3 nM. CI-1020 blocks intimal hyperplasia in human saphenous veins completely in organ culture. CI 1020 inhibits hypoxic pulmonary hypertension and blocks ET-1-induced pressor responses following oral administration[1][2][3]. |
Name | 3-(1,3-benzodioxol-5-yl)-5-hydroxy-5-(4-methoxyphenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]furan-2-one |
---|---|
Synonym | More Synonyms |
Description | CI-1020 (PD156707) is an orally active and selective antagonist targeting endothelin (ETA) with an IC50 value of 0.3 nM. CI-1020 blocks intimal hyperplasia in human saphenous veins completely in organ culture. CI 1020 inhibits hypoxic pulmonary hypertension and blocks ET-1-induced pressor responses following oral administration[1][2][3]. |
---|---|
Related Catalog | |
Target |
ETA:0.3 nM (IC50) |
References |
Density | 1.351g/cm3 |
---|---|
Boiling Point | 722.338ºC at 760 mmHg |
Molecular Formula | C28H26O9 |
Molecular Weight | 506.50 |
Flash Point | 242.505ºC |
Exact Mass | 506.15800 |
PSA | 101.91000 |
LogP | 3.84810 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.623 |
~% CI 1020 CAS#:162256-50-0 |
Literature: Journal of Medicinal Chemistry, , vol. 42, # 12 p. 2162 - 2168 |
~% CI 1020 CAS#:162256-50-0 |
Literature: Journal of Medicinal Chemistry, , vol. 42, # 12 p. 2162 - 2168 |
~% CI 1020 CAS#:162256-50-0 |
Literature: Journal of Medicinal Chemistry, , vol. 38, # 8 p. 1259 - 1263 |
~% CI 1020 CAS#:162256-50-0 |
Literature: Journal of Medicinal Chemistry, , vol. 42, # 12 p. 2162 - 2168 |
Precursor 3 | |
---|---|
DownStream 0 |
PPADS tetrasodium salt |
CI 1020 |